Meanwhile, FNDC5 overexpression in early life significantly reduced the numbers of SA β‐gal‐positive cells and alleviated cardiac hypertrophy and fibrosis in aging hearts (Figure S11E‐H). The gene discussed is GAL; the disease is cardiac hypertrophy.